Generation of a Fully Human scFv that binds Tumor-Specific Glycoforms
Open Access
- 25 March 2019
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-11
Abstract
Tumor-specific glycosylation changes are an attractive target for the development of diagnostic and therapeutic applications. Periostin is a glycoprotein with high expression in many tumors of epithelial origin including ovarian cancer. Strategies to target the peptide portion of periostin as a diagnostic or therapeutic biomarker for cancer are limited due to increased expression of periostin in non-cancerous inflammatory conditions. Here, we have screened for antibody fragments that recognize the tumor-specific glycosylation present on glycoforms of periostin containing bisecting N-glycans in ovarian cancer using a yeast-display library of antibody fragments, while subtracting those that bind to the periostin protein with glycoforms found in non-malignant cell types. We generated a biotinylated form of a fully human scFv antibody (scFvC9) that targets the bisecting N-glycans expressed by cancer cells. Validation studies in vitro and in vivo using scFvC9 indicate this antibody can be useful for the development of diagnostic, imaging, and therapeutic applications for cancers that express the antigen.Keywords
Funding Information
- National Institutes of Health (UO1CA168870)
This publication has 44 references indexed in Scilit:
- Blocking the B7-H4 pathway with novel recombinant antibodies enhances T cell-mediated antitumor responsesOncoImmunology, 2013
- Validation of glypican-3-specific scFv isolated from paired display/secretory yeast display libraryBMC Biotechnology, 2012
- Immune recognition of tumor-associated mucin MUC1 is achieved by a fully synthetic aberrantly glycosylated MUC1 tripartite vaccineProceedings of the National Academy of Sciences, 2011
- Mannose Receptor (MR) Engagement by Mesothelin GPI Anchor Polarizes Tumor-Associated Macrophages and Is Blocked by Anti-MR Human Recombinant AntibodyPLOS ONE, 2011
- Rapid isolation of high-affinity human antibodies against the tumor vascular marker Endosialin/TEM1, using a paired yeast-display/secretory scFv library platformJournal of Immunological Methods, 2011
- Identification of candidate biomarkers with cancer‐specific glycosylation in the tissue and serum of endometrioid ovarian cancer patients by glycoproteomic analysisProteomics, 2010
- Glycomics Profiling of Chinese Hamster Ovary Cell Glycosylation Mutants Reveals N-Glycans of a Novel Size and ComplexityJournal of Biological Chemistry, 2010
- Method for generation of in vivo biotinylated recombinant antibodies by yeast matingJournal of Immunological Methods, 2006
- Development of a Human Light Chain Variable Domain (VL) Intracellular Antibody Specific for the Amino Terminus of Huntingtin via Yeast Surface DisplayJournal of Molecular Biology, 2004
- Yeast mating for combinatorial Fab library generation and surface displayFEBS Letters, 2004